Related Experiment Videos
Cranial computed tomography (CCT) findings in children treated with ACTH and dexamethasone: first results
Insights
Adrenocorticotropic hormone (ACTH) and dexamethasone treatment in children with epilepsy caused temporary brain changes, which resolved after therapy. These reversible effects suggest brain plasticity and may impact cerebral edema treatment strategies.
Area of Science:
- Pediatric Neurology
- Neuroendocrinology
- Radiology
Background:
- Petit mal epilepsy in children requires effective treatment.
- Corticosteroids like ACTH and dexamethasone are used in epilepsy management.
- Understanding treatment-related neurological effects is crucial.
Purpose of the Study:
- To investigate the impact of ACTH and dexamethasone on cerebral structures in children with petit mal epilepsy.
- To assess the reversibility of treatment-induced changes.
- To explore implications for managing cerebral edema.
Main Methods:
- Systematic treatment of 8 children with petit mal epilepsy using ACTH and dexamethasone.
- Serial Computed Tomography (CCT) examinations before, during, and after hormonal therapy.
- Clinical observation for developmental changes.
Main Results:
- Severe cerebral changes, including enlarged ventricles and subarachnoid space, observed during ACTH treatment.
- Similar, less severe changes noted with dexamethasone.
- Complete resolution of cerebral changes after cessation of hormonal therapy.
- Observed developmental spurts in many children post-treatment without relapses.
Conclusions:
- Hormonal therapy for epilepsy in children can induce reversible cerebral changes.
- These findings suggest significant morphological plasticity of brain structures.
- The results have implications for the therapeutic approach to cerebral edema.
Abstract:
8 children with different petit mal epilepsies were systematically treated with ACTH and dexamethasone. CCT examinations were performed before, during and after treatment. In all children severe cerebral changes. enlargement of ventricles and subarachnoid space developed during the initial phase of treatment with Depot-ACTH. Similar changes, but to a less severe degree, could be demonstrated during the phase of dexamethasone therapy thereafter. In all patients cerebral changes disappeared after hormonal treatment had ended. At this point many children had a developmental spurt, developmental relapses could not be observed. It is suggested that these reversible changes seen on CCT scans represent a form of morphological plasticity of brain structures. These results bear certain consequences as to the therapy of cerebral edema.